Adisu Biotech Solutions Private Limited
About Adisu Biotech Solutions Private Limited
Data last updated:
Adisu Biotech Solutions Private Limited was a private limited company based in Greater Noida, Uttar Pradesh, India, operated as a subsidiary of Adisu International Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the chemical products segment of the chemicals sector. It was incorporated on 10 December 2014.
The company was registered with the Registrar of Companies (ROC), Kanpur, under CIN U74120UP2014PTC067515.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Pradeep Kumar and Sujata Kumari.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at K – 132 Delta – 2 Gautam Budh Nagar, Greater Noida, Uttar Pradesh, India – 201308.
As per the financials filed for FY 2021, the company reported a revenue of ₹1.81 Lakh, a decline of 27% compared to the previous year. For the same year it recorded a net profit of ₹24,509 (net margin 13.5%) and EBITDA of ₹33,120 (EBITDA margin 18.3%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 23% over five years.
Company details
Contact details
Adisu Biotech Solutions Private Limited's registered office is in Greater Noida, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressK – 132 Delta – 2 Gautam Budh Nagar, Greater Noida, Uttar Pradesh, India – 201308
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Adisu Biotech Solutions Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Adisu Biotech Solutions is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Adisu Biotech Solutions Private Limited
FY 2021 filings availableAdisu Biotech Solutions Private Limited reported revenue of ₹1.81 Lakh (down 27% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue fell 27% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 23%. EBITDA fell 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33,120 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24,509 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.3% | ||||
| Net Profit Margin | 13.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adisu Biotech Solutions Private Limited, buy the company report.
Board of directors of Adisu Biotech Solutions Private Limited
Adisu Biotech Solutions has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pradeep Kumar Also directs: Adisu LLP, Adisu International Private Limited | Director | 26 Mar 2020 | 6 Years 7 Months | As last reported |
| Sujata Kumari Also directs: Adisu LLP, Adisu International Private Limited | Director | 10 Dec 2014 | 11 Years 10 Months | As last reported |
Peer comparison
Adisu Biotech Solutions Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Epo-Chemie Private Ltd | ₹1.84 Lakh (FY 2024) | 24.0% | Thane, Maharashtra, India | |||
| Omnilucid Private Limited | ₹1.82 Lakh (FY 2021) | 85.0% | Faridabad, Haryana, India | |||
| Pepthera Laboratories Private Limited | ₹1.82 Lakh (FY 2025) | -87.0% | Guwahati, Assam, India | |||
| Deoghar Clean Fuel Private Limited | ₹1.82 Lakh (FY 2025) | -22.0% | Sarwan, Jharkhand, India | |||
| Genisis Pharmaceutical (OPC) Private Limited | ₹1.82 Lakh (FY 2020) | -67.0% | Sangamner, Maharashtra, India | |||
| Adisu Biotech Solutions Private Limitedthis company | ₹1.81 Lakh (FY 2021) | ₹24,509 | 13.5% | -27.0% | Greater Noida, Uttar Pradesh, India | |
| Sarvashreshth Ventures Private Limited | ₹1.81 Lakh (FY 2024) | Gmc, Assam, India | ||||
| Alviv Pharmaceuticals Private Limited | ₹1.81 Lakh (FY 2019) | Chikuwadi Daman, Daman and Diu, India | ||||
| Costales Private Limited | ₹1.81 Lakh (FY 2024) | 49.0% | Nagpur, Maharashtra, India | |||
| Eyeconic Pharmaceuticals (India) Private Limited | ₹1.81 Lakh (FY 2021) | -91.0% | Aurangabad, Maharashtra, India | |||
| Balaji Universal Supplier Private Limited | ₹1.81 Lakh (FY 2025) | 48.0% | Pune, Maharashtra, India |
To see the full peer comparison of Adisu Biotech Solutions Private Limited, buy the company report.
Auditor
Adisu Biotech Solutions Private Limited is audited by ANKIT AJAY K AGRAWAL & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANKIT AJAY K AGRAWAL & CO. | FY 2017 | 025915N |
Shareholding
The shareholding of Adisu Biotech Solutions Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Adisu Biotech Solutions Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Adisu Biotech Solutions Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adisu Biotech Solutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Adisu Biotech Solutions Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Adisu Biotech Solutions Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Pradeep Kumar ceased to be Additional Director on 31 Dec 2020.
Frequently asked questions
Adisu Biotech Solutions has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Adisu Biotech Solutions was a private limited company based in Greater Noida, Uttar Pradesh, India. The company worked in chemical products, within the chemicals industry. It was incorporated on 10 December 2014 and is registered under CIN U74120UP2014PTC067515. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Adisu Biotech Solutions was incorporated on 10 December 2014. It is registered with the Registrar of Companies, Kanpur.
Adisu Biotech Solutions had 2 directors:
- Pradeep Kumar - Director
- Sujata Kumari - Director
The CIN (Corporate Identification Number) of Adisu Biotech Solutions is U74120UP2014PTC067515. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Adisu Biotech Solutions is at K – 132 Delta – 2 Gautam Budh Nagar, Greater Noida, Uttar Pradesh, India – 201308.
The latest financial statements of Adisu Biotech Solutions on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
Adisu Biotech Solutions operated in the chemicals industry, in the chemical products segment.
The peers of Adisu Biotech Solutions by revenue are Epo-Chemie Private Ltd, Omnilucid Private Limited, Pepthera Laboratories Private Limited, Deoghar Clean Fuel Private Limited, Genisis Pharmaceutical (OPC) Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pradeep Kumar ceased to be Additional Director on 31 Dec 2020. Aditya Krishna ceased to be Director on 26 Mar 2020. Pradeep Kumar was appointed as Director on 26 Mar 2020. Adisu Biotech Solutions has 4 board changes on record in total.
The compliance status of Adisu Biotech Solutions is compliant as of 04 August 2026.